YOKNEAM, ISRAEL--(Marketwire - November 11, 2008) - Syneron Medical Ltd. (NASDAQ: ELOS), an innovator in the development, marketing and sales of elos™ combined-energy medical aesthetic devices, today announced that its board of directors adopted a shareholder rights plan. The shareholder rights plan is designed to protect against any potential future use of coercive or abusive takeover techniques designed to gain control of the Company and its capital without full and fair value being paid to all of the Company’s shareholders. The shareholder rights plan was adopted following evaluation and consultation with outside advisors in consideration of the Company’s current low valuation and strong cash position.
